KindredBio Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:$11.5M
Industry:Biotech
Founded:2012
Lead Investor(s):Barclays Capital Inc, Stifel
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • KindredBio's estimated revenue is currently $16.3M per year.
  • KindredBio received $46.0M in venture funding in January 2019.
  • KindredBio's estimated revenue per employee is $145313
  • KindredBio's total funding is $11.5M.

Employee Data

  • KindredBio has 112 Employees.
  • KindredBio grew their employee count by 12% last year.
  • KindredBio currently has 3 job openings.

Executive Contacts

NameTitle
Jessica LeeDirector, Project Management
Yuan XiangDirector, Head of Statistical Programming
Melinda Poole O'BanionExecutive Director, Clinical Development and Regulatory Affairs
Russell RadefeldDirector, Operations and IT
Theresa L'HommeAssociate Director Project Management
Rebecca PeskinAssociate Director Marketing at KindredBiosciences
Renee HelmsAssociate Director, Veterinary Pharmacovigilance
Elizabeth KeeDirector
Matt ApplegateDirector, Commercial Manufacturing and Site Director
Ted OliphantDirector of Biomanufacturing

What Is KindredBio?

Our goal is to save lives and relieve suffering for the animals in our lives. We bring a determination and dedication to unite our expertise and research creativity in developing humane, effective, and safe therapies for our animal companions that people enjoy today. We are veterinary therapeutics, redefined. As one of the first pet biotech companies in the world, we understood early that to quickly deliver veterinary therapeutics in unmet and under served areas we needed a revolutionary approach. By leveraging the similarities between human and pet diseases, we are creating cutting edge versions of successful human drugs and biologics. Our belief is that this can substantially increase success rate and reduce time to market - increasing the quality of life for the pets with whom we share so much of our lives, providing the veterinary community with innovative treatment options, and, we anticipate, generating solid returns for our investors.

keywords:Biotechnology,Healthcare,Pharmaceuticals

112

Number of Employees

$16.3M

Revenue (est)

3

Current Jobs

12%

Employee Growth %

$11.5M

Total Funding

N/A

Valuation

N/A

Accelerator

B2C

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
DiaCarta
$6.2M4310%$53M
Mission Bio
$10.7M7445%
Rigel Pharmaceu...
$42M2904%
ProTrials Resea...
$26.4M1823%
Trace Genomics
$5.9M4137%
Advanced Cell D...
$25.7M1788%
CellMax Life
$5.7M4011%$9M
Vaxart
$4.2M33-15%$58.6M
Full Spectrum A...
$6M425%
Calysta
$7.1M49-2%

KindredBio News

12-Sep-19 - Kindred Biosciences Awarded a Contract by the National ...

As a cGMP pool contractor, KindredBio is eligible to provide manufacturing, formulation and analytical services to meet the needs of the ...

31-Aug-19 - Kindred Biosciences to Participate in HC Wainwright Global ...

During this time, investors will have the opportunity to discuss recent developments, including the launch of KindredBio's first product, study ...

17-Aug-19 - Canine parvovirus treatment may be in the works

KindredBio has released positive results from a pilot efficacy study of KIND-030, a chimeric, high-affinity monoclonal antibody targeting the ...

KindredBio Funding

DateAmountRoundLead InvestorsReference
2014-03-19$UndisclosedUndisclosedLeerink Partners LLCArticle
2014-04-04$54.0MUndisclosedLeerink Partners LLCArticle
2014-04-09$58.1MUndisclosedLeerink Partners LLCArticle
2017-07-13$25.8MUndisclosedLadenburg Thalmann & Co. IncArticle
2018-06-26$57.2MUndisclosedCantor Fitzgerald & CoArticle
2019-01-21$46.0MUndisclosedBarclays Capital IncArticle

KindredBio Executive Hires

DateNameTitleReference
2014-03-25Blake HawleyChief Commercial OfficerArticle
2015-05-29Jennifer ElliottVP Legal Affairs/Intellectual PropertyArticle
2017-09-12Hangjun ZhanChief Scientific OfficerArticle
2018-10-24Denise BeversCo-Founder/President/COOArticle